Content about Insight Pharmaceutical

NEW YORK — Where do women turn for information on more sensitive health topics? Do women believe that men’s health issues get more attention in the media? To get answers to these questions, as well as many others, DSNTV recently took to the streets of Manhattan to speak with women to get their perspectives.

The video, titled “Insights Into Women’s Health,” is the first of a two-part series sponsored by Insight Pharmaceuticals, whose brand portfolio includes EPT and Monistat.

TREVOSE, Pa. — Research has shown that three in four women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced Wednesday, citing an independent survey commissioned for Monistat.

PHILADELPHIA — Insight Pharmaceuticals recently selected Neiman as creative partner for its portfolio of over-the-counter women’s health and personal care brands, the ad agency announced Tuesday.

“Insight wanted a creative partner who could help them to create purposeful conversations with each of their brands’ consumers,” stated Neiman president Amy Muntz. “That’s the kind of client and assignment that great agencies crave, and it’s an honor to have won.”

LANGHORNE, Pa. — Insight Pharmaceuticals is voluntarily recalling one lot of a nasal decongestant due to the possibility of bacterial contamination, the company said.

Insight said it would recall lot number 11G075, UPC code 6373673005, of Nostrilla nasal spray to the consumer level because of possible contamination with Burkholderia cepacia bacteria. The lot, which contains 34,092 bottles, was distributed nationwide to retail outlets.

LANGHORNE, Pa. — Insight Pharmaceuticals is strengthening its portfolio of over-the-counter products with its acquisition of a popular at-home pregnancy test.

Insight said that e.p.t. will join other Insight brands, including Sucrets, Nix, Bonine and Gentle Naturals. As the first FDA-approved, commercially available home pregnancy test, e.p.t. aligns with Insight's strategy to build "a significant portfolio of OTC and personal care products," Insight's CEO Gary Downing said.

LANGHORNE, Pa. —Insight Pharmaceutical has made a point this year to tie its Auro-Dri ear care product into the summer swimming season, and is raising quite a bit of awareness among moms in the process.